PL358100A1 - Preparat o aktywności mobilizującej - Google Patents

Preparat o aktywności mobilizującej

Info

Publication number
PL358100A1
PL358100A1 PL01358100A PL35810001A PL358100A1 PL 358100 A1 PL358100 A1 PL 358100A1 PL 01358100 A PL01358100 A PL 01358100A PL 35810001 A PL35810001 A PL 35810001A PL 358100 A1 PL358100 A1 PL 358100A1
Authority
PL
Poland
Prior art keywords
formulation
mobilising
activity
mobilising activity
haematopoietic
Prior art date
Application number
PL01358100A
Other languages
English (en)
Inventor
Laura Ferro
Roberto Porta
Massimo Iacobelli
Alessandro Massimo Gianni
Carmelo Carlo Stella
Original Assignee
Gentium Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentium Spa filed Critical Gentium Spa
Publication of PL358100A1 publication Critical patent/PL358100A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL01358100A 2000-04-18 2001-04-10 Preparat o aktywności mobilizującej PL358100A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00830293A EP1147777A1 (en) 2000-04-18 2000-04-18 Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
PCT/EP2001/004105 WO2001078761A2 (en) 2000-04-18 2001-04-10 Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors

Publications (1)

Publication Number Publication Date
PL358100A1 true PL358100A1 (pl) 2004-08-09

Family

ID=8175292

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01358100A PL358100A1 (pl) 2000-04-18 2001-04-10 Preparat o aktywności mobilizującej

Country Status (31)

Country Link
US (1) US20040131588A1 (pl)
EP (3) EP1147777A1 (pl)
JP (1) JP5205668B2 (pl)
KR (1) KR100849491B1 (pl)
CN (1) CN1183962C (pl)
AT (2) ATE310532T1 (pl)
AU (2) AU5832201A (pl)
BG (1) BG107203A (pl)
CA (1) CA2406179C (pl)
CY (1) CY1104971T1 (pl)
CZ (1) CZ20023426A3 (pl)
DE (2) DE60115222T2 (pl)
DK (2) DK1276497T3 (pl)
EE (1) EE200200596A (pl)
ES (2) ES2252227T3 (pl)
HR (1) HRP20020835A2 (pl)
HU (1) HUP0300560A3 (pl)
IL (1) IL152328A (pl)
IS (1) IS2171B (pl)
MX (1) MXPA02010346A (pl)
NO (1) NO20024988L (pl)
NZ (1) NZ522016A (pl)
PL (1) PL358100A1 (pl)
PT (1) PT1621207E (pl)
RO (1) RO121006B1 (pl)
RU (1) RU2248216C2 (pl)
SI (1) SI21079B (pl)
SK (1) SK14892002A3 (pl)
UA (1) UA73566C2 (pl)
WO (1) WO2001078761A2 (pl)
ZA (1) ZA200208413B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8771663B2 (en) 2000-04-18 2014-07-08 Gentium Spa Formulation having mobilising activity
US20050069553A1 (en) 2003-08-13 2005-03-31 Yi Zheng Chimeric peptides for the regulation of GTPases
EP1656156A2 (en) * 2003-08-13 2006-05-17 Children's Hospital Medical Center Mobilization of hematopoietic cells
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
RU2376985C1 (ru) * 2008-07-17 2009-12-27 Владислав Николаевич Ласкавый Средство для активации стволовых клеток
US8980862B2 (en) 2010-11-12 2015-03-17 Gentium S.P.A. Defibrotide for use in prophylaxis and/or treatment of Graft versus Host Disease (GVHD)
BR112014031934B1 (pt) 2012-06-22 2021-05-04 Gentium S.R.L. método com base em euglobulina para determinar a atividade biológica de defibrotide
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
CN106567694A (zh) * 2016-11-14 2017-04-19 北京国泰通源技术有限公司 智能控水短节
EP3574103A4 (en) * 2018-01-12 2020-09-23 Cellmig Biolabs Inc. METHOD FOR GENERATING CYTOCAPSULES AND CYTOCAPSULA TUBE
CN114730031B (zh) 2019-11-13 2024-04-12 富士胶片株式会社 装饰膜、成型物及电子器件

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1043823B (it) 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
US3899481A (en) 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
IT1206341B (it) 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4694134A (en) 1985-05-28 1987-09-15 Ajax Magnethermic Corporation Apparatus for overheating edges of skelp for the production of compression welded pipe
US5223609A (en) 1986-04-17 1993-06-29 Crinos Industria Farmacobiologica S.P.A. Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
IT1190313B (it) 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
JP2907447B2 (ja) * 1988-08-24 1999-06-21 中外製薬株式会社 抗血栓剤
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
JP3021906B2 (ja) * 1992-01-28 2000-03-15 松下電器産業株式会社 電動調理機
JPH08127539A (ja) * 1994-10-31 1996-05-21 Ajinomoto Co Inc ヒトｉｌ−１１を含有する末梢血幹細胞増加剤
EP0801076A4 (en) * 1994-11-30 1999-12-15 Chugai Pharmaceutical Co Ltd THROMBOCYTOTIC FACTOR
EP0937461B1 (en) * 1996-07-10 2005-07-06 Meiji Dairies Corporation Use of proteins from the mk family as hematopoietic factor
AU1705599A (en) * 1997-11-26 1999-06-15 Allegheny University Of The Health Sciences Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
US6573372B2 (en) * 1999-01-07 2003-06-03 Heska Corporation Feline immunoglobulin E molecules and compositions there of

Also Published As

Publication number Publication date
ZA200208413B (en) 2003-10-17
HUP0300560A3 (en) 2005-07-28
DE60115222T2 (de) 2006-08-10
HRP20020835A2 (en) 2005-10-31
NZ522016A (en) 2004-10-29
AU5832201A (en) 2001-10-30
EP1621207A3 (en) 2006-11-22
WO2001078761A3 (en) 2002-01-24
NO20024988D0 (no) 2002-10-16
SI21079B (sl) 2006-08-31
UA73566C2 (en) 2005-08-15
WO2001078761A2 (en) 2001-10-25
IS2171B (is) 2006-11-15
ES2252227T3 (es) 2006-05-16
JP5205668B2 (ja) 2013-06-05
RU2002130719A (ru) 2004-03-27
MXPA02010346A (es) 2004-09-06
EP1147777A1 (en) 2001-10-24
DE60115222D1 (de) 2005-12-29
DK1621207T3 (da) 2010-02-01
RU2248216C2 (ru) 2005-03-20
IL152328A0 (en) 2003-05-29
JP2004500437A (ja) 2004-01-08
IS6581A (is) 2002-10-14
ATE443524T1 (de) 2009-10-15
PT1621207E (pt) 2009-12-28
CA2406179A1 (en) 2001-10-25
ATE310532T1 (de) 2005-12-15
KR20030010603A (ko) 2003-02-05
US20040131588A1 (en) 2004-07-08
NO20024988L (no) 2002-12-02
CY1104971T1 (el) 2010-03-03
EP1276497A2 (en) 2003-01-22
BG107203A (bg) 2003-05-30
RO121006B1 (ro) 2006-11-30
HUP0300560A2 (hu) 2003-06-28
EP1621207A2 (en) 2006-02-01
CA2406179C (en) 2012-03-27
DK1276497T3 (da) 2006-03-27
EP1621207B1 (en) 2009-09-23
DE60140015D1 (de) 2009-11-05
AU2001258322B2 (en) 2006-03-16
EP1276497B1 (en) 2005-11-23
ES2335776T3 (es) 2010-04-05
CZ20023426A3 (cs) 2003-05-14
IL152328A (en) 2009-12-24
EE200200596A (et) 2004-04-15
SI21079A (sl) 2003-06-30
SK14892002A3 (sk) 2003-06-03
CN1434719A (zh) 2003-08-06
CN1183962C (zh) 2005-01-12
KR100849491B1 (ko) 2008-07-31

Similar Documents

Publication Publication Date Title
AU5832201A (en) Formulation having mobilising activity
MY123140A (en) Disposable absorbent article with containment structure
NO20061095L (no) Vertscelle som fremstiller chimerisk anti-CD2o-antistoff samt anvendelse derav ved fremstilling av medikamenter til behandling av lidelser som involverer B-celler
MY128208A (en) Body fluids absorbent article
WO2000030622A3 (de) Verwendung von dialkylfumaraten zur behandlung von host-versus-graft reaktionen und von autoimmunerkrankungen
PT1083899E (pt) Derivados de 1-desoxi-galactonojirimicina e respectiva utilização no tratamento de doenças de acumulação lisossomal, por intensificação da alfa-galactosidase a lisossomal
DE69936545D1 (de) Saugfähiger gegenstand
GB9415167D0 (en) Improvements relating to cancer therapy
MXPA02003809A (es) Articulo absorbente desechable con estructura de contencion.
AU2001269688A1 (en) Combination containing an antifolate and methylmalonic acid lowering agent
AU2001261986A1 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
EP1304108A3 (en) Anti-arrhythmic composition and methods of treatment
YU79802A (sh) Formulacija sa aktivnošću mobilizacije
EP1123100A4 (en) MEMORY IMPROVEMENT BY ADMINISTRATION OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION AND 3-BETA-ESTERS THEREOF
EP0340933A3 (en) Heparin-containing formulations
AU6373699A (en) Support pad
AU7719491A (en) Therapeutic compound
Kim et al. Synergistic Cooperation Between Human Chorionic Gonadotropin and rIFN-Υ for Induction of Nitric Oxide Synthesis
UA28031C2 (uk) Лікарська форма похідних 5- нітроімідазолу, фармацевтична композиція для лікування паразитарних та інфекційних захворювань шлунково-кишкового тракту, гастрозахищені мікрогранули похідних 5-нітроімідазолу, мікрогранули поkідних 5-нітроімідазолу з пролонгов
ES2086518T3 (es) Compuesto farmaceutico con accion cicatrizante.
UA30444A (uk) Спосіб лікування ювенільної маткової кровотечі
UA1032U (uk) Ректопростатоскоп

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)